Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kee Moon

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analogJaekwang Lee, Suyeal Bae, Seo-Hee Lee, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
Synthesis of novel diaryl ethers and their evaluation as antimitotic agentsJin-Kyung In, Mi-Sung Lee, Jung-Eun Yang, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2009
Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533)Hojin Choi, Jaekwang Lee, Young Hoon Kim, et al.
Scientific Reports|February 1, 2022
Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopeciaSung-Il Yun, Sang-Kyu Lee, Eun-Ah Goh, et al.
Journal of Medicinal Chemistry|August 10, 2010
Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumorsJaekwang Lee, Soo Jin Kim, Hojin Choi, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2008
Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunctionYoung Hoon Kim, Hojin Choi, Jaekwang Lee, et al.
Brain : a Journal of Neurology|May 5, 2023
TGFβ4 alleviates the phenotype of Charcot-Marie-Tooth disease type 1AHyeonjin Jeon, So Young Jang, Geon Kwak, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analogJaekwang Lee, Suyeal Bae, Seo-Hee Lee, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
Synthesis of novel diaryl ethers and their evaluation as antimitotic agentsJin-Kyung In, Mi-Sung Lee, Jung-Eun Yang, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2009
Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533)Hojin Choi, Jaekwang Lee, Young Hoon Kim, et al.
Scientific Reports|February 1, 2022
Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopeciaSung-Il Yun, Sang-Kyu Lee, Eun-Ah Goh, et al.
Journal of Medicinal Chemistry|August 10, 2010
Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumorsJaekwang Lee, Soo Jin Kim, Hojin Choi, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2008
Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunctionYoung Hoon Kim, Hojin Choi, Jaekwang Lee, et al.
Brain : a Journal of Neurology|May 5, 2023
TGFβ4 alleviates the phenotype of Charcot-Marie-Tooth disease type 1AHyeonjin Jeon, So Young Jang, Geon Kwak, et al.
Pageof 5